These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18419109)

  • 21. Protective effect of colostrinin on neuroblastoma cell survival is due to reduced aggregation of beta-amyloid.
    Schuster D; Rajendran A; Hui SW; Nicotera T; Srikrishnan T; Kruzel ML
    Neuropeptides; 2005 Aug; 39(4):419-26. PubMed ID: 15890402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of fibril formation in beta-amyloid peptide by a novel series of benzofurans.
    Howlett DR; Perry AE; Godfrey F; Swatton JE; Jennings KH; Spitzfaden C; Wadsworth H; Wood SJ; Markwell RE
    Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):283-9. PubMed ID: 10229684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation.
    Luo W; Li YP; He Y; Huang SL; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS
    Bioorg Med Chem; 2011 Jan; 19(2):763-70. PubMed ID: 21211982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein.
    Akaishi T; Morimoto T; Shibao M; Watanabe S; Sakai-Kato K; Utsunomiya-Tate N; Abe K
    Neurosci Lett; 2008 Oct; 444(3):280-5. PubMed ID: 18761054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Syntheses and characterization of novel oxoisoaporphine derivatives as dual inhibitors for cholinesterases and amyloid beta aggregation.
    Li YP; Ning FX; Yang MB; Li YC; Nie MH; Ou TM; Tan JH; Huang SL; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2011 May; 46(5):1572-81. PubMed ID: 21367493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Brunhofer G; Fallarero A; Karlsson D; Batista-Gonzalez A; Shinde P; Gopi Mohan C; Vuorela P
    Bioorg Med Chem; 2012 Nov; 20(22):6669-79. PubMed ID: 23062825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Phenoxy-indan-1-one derivatives as acetylcholinesterase inhibitors: a study on the importance of modifications at the side chain on the activity.
    Shen Y; Sheng R; Zhang J; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2008 Aug; 16(16):7646-53. PubMed ID: 18662884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    He Y; Yao PF; Chen SB; Huang ZH; Huang SL; Tan JH; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2013 May; 63():299-312. PubMed ID: 23501115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238.
    Rizzo S; Bartolini M; Ceccarini L; Piazzi L; Gobbi S; Cavalli A; Recanatini M; Andrisano V; Rampa A
    Bioorg Med Chem; 2010 Mar; 18(5):1749-60. PubMed ID: 20171894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aminostyrylbenzofuran derivatives as potent inhibitors for Abeta fibril formation.
    Byun JH; Kim H; Kim Y; Mook-Jung I; Kim DJ; Lee WK; Yoo KH
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5591-3. PubMed ID: 18793854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extensive SAR and computational studies of 3-{4-[(benzylmethylamino)methyl]phenyl}-6,7-dimethoxy-2H-2-chromenone (AP2238) derivatives.
    Piazzi L; Cavalli A; Belluti F; Bisi A; Gobbi S; Rizzo S; Bartolini M; Andrisano V; Recanatini M; Rampa A
    J Med Chem; 2007 Aug; 50(17):4250-4. PubMed ID: 17655212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.
    Arce MP; Rodríguez-Franco MI; González-Muñoz GC; Pérez C; López B; Villarroya M; López MG; García AG; Conde S
    J Med Chem; 2009 Nov; 52(22):7249-57. PubMed ID: 19856923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer.
    Tumiatti V; Milelli A; Minarini A; Rosini M; Bolognesi ML; Micco M; Andrisano V; Bartolini M; Mancini F; Recanatini M; Cavalli A; Melchiorre C
    J Med Chem; 2008 Nov; 51(22):7308-12. PubMed ID: 18954037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tacripyrines, the first tacrine-dihydropyridine hybrids, as multitarget-directed ligands for the treatment of Alzheimer's disease.
    Marco-Contelles J; León R; de los Ríos C; Samadi A; Bartolini M; Andrisano V; Huertas O; Barril X; Luque FJ; Rodríguez-Franco MI; López B; López MG; García AG; Carreiras Mdo C; Villarroya M
    J Med Chem; 2009 May; 52(9):2724-32. PubMed ID: 19374444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, biological evaluation and molecular modeling of benzofuran piperidine derivatives as Aβ antiaggregant.
    Chowdhury SR; Gu J; Hu Y; Wang J; Lei S; Tavallaie MS; Lam C; Lu D; Jiang F; Fu L
    Eur J Med Chem; 2021 Oct; 222():113541. PubMed ID: 34116326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents.
    Luo W; Li YP; He Y; Huang SL; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2011 Jun; 46(6):2609-16. PubMed ID: 21497959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and biological evaluation of conformationally restricted rivastigmine analogues.
    Bolognesi ML; Bartolini M; Cavalli A; Andrisano V; Rosini M; Minarini A; Melchiorre C
    J Med Chem; 2004 Nov; 47(24):5945-52. PubMed ID: 15537349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abeta-globulomers are formed independently of the fibril pathway.
    Gellermann GP; Byrnes H; Striebinger A; Ullrich K; Mueller R; Hillen H; Barghorn S
    Neurobiol Dis; 2008 May; 30(2):212-20. PubMed ID: 18353662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer's Disease.
    Rampa A; Bartolini M; Pruccoli L; Naldi M; Iriepa I; Moraleda I; Belluti F; Gobbi S; Tarozzi A; Bisi A
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30061534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.